Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Company Info
Contact US
Biomedican
Drug Discovery & Development
Overview
Contact US
Contributions
Contributors
Contributions
1 Contributors
1 / 1
1 / 1
2 Contributions
1 / 1
1 / 1
Maxim Mikheev, M.D., Ph.D.
Chief Executive Officer and Founder
Leveraging Biosynthesis to Create Pure Cannabinoids for Less
Maxim Mikheev, M.D., Ph.D.
Biomedican
PA1167
Dec 08, 2020
Cannabinoids
BIOMEDICAN Announces Successful Biosynthesis and Large-Scale Production of Rare Cannabinoids CBG/CBGA
Biomedican
PR-M11-20-010
Nov 12, 2020
